產(chǎn)品詳情
簡單介紹:
rTertiapin(TPN)
詳情介紹:
Sequence | ALCNCNRIII PHMCWKKCGK K. |
Specificity | Tertiapin blocks a range of inward rectifier K+ channels (Kir) in particular ROMK1 and GIRK but with no effect on Kir2 family members1. In addition, it was shown to inhibit acetylcholine induced K+ currents in heart2,3. |
Characteristics |
Source: Apis mellifera (Honeybee). Molecular formula: C106H175N33O23S5. Disulfide bonds between Cys3-Cys14, and Cys5-Cys18. |
Purity | > 98 % |
Molecular Weight | 2456 |
Application Notes | 10-100 nM |
Restrictions | For Research Use only |
Format | Lyophilized |
Reconstitution |
Any aqueous buffer. Centrifuge all product preparations before use (10000 x g 5 min). Concentration after reconstitution: Dissolving 50g in 2.036 ml will provide a stock solution of 10 M. |
Handling Advice | Soluble in Water. |
Product cited in: |
Drici, Diochot, Terrenoire, Romey, Lazdunski: "The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocks." in: British journal of pharmacology, Vol. 131, Issue 3, pp. 569-77, 2000 (PubMed).
Kitamura, Yokoyama, Akita, Matsushita, Kurachi, Yamada: "Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes." in: The Journal of pharmacology and experimental therapeutics, Vol. 293, Issue 1, pp. 196-205, 2000 (PubMed). Jin, Lu: "A novel high-affinity inhibitor for inward-rectifier K+ channels." in: Biochemistry, Vol. 37, Issue 38, pp. 13291-9, 1998 (PubMed). |